136 related articles for article (PubMed ID: 10076566)
1. Association of MTG8 (ETO/CDR), a leukemia-related protein, with serine/threonine protein kinases and heat shock protein HSP90 in human hematopoietic cell lines.
Komori A; Sueoka E; Fujiki H; Ishii M; Kozu T
Jpn J Cancer Res; 1999 Jan; 90(1):60-8. PubMed ID: 10076566
[TBL] [Abstract][Full Text] [Related]
2. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1.
Tanaka K; Tanaka T; Kurokawa M; Imai Y; Ogawa S; Mitani K; Yazaki Y; Hirai H
Blood; 1998 Mar; 91(5):1688-99. PubMed ID: 9473235
[TBL] [Abstract][Full Text] [Related]
3. Tumourigenicity of MTG8, a leukaemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells.
Sueoka E; Sueoka N; Okabe S; Komori A; Suganuma M; Kozu T; Fujiki H
Br J Haematol; 1998 Jun; 101(4):737-42. PubMed ID: 9674748
[TBL] [Abstract][Full Text] [Related]
4. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon.
Shimizu K; Kitabayashi I; Kamada N; Abe T; Maseki N; Suzukawa K; Ohki M
Blood; 2000 Jul; 96(1):288-96. PubMed ID: 10891464
[TBL] [Abstract][Full Text] [Related]
5. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
Miyoshi H; Kozu T; Shimizu K; Enomoto K; Maseki N; Kaneko Y; Kamada N; Ohki M
EMBO J; 1993 Jul; 12(7):2715-21. PubMed ID: 8334990
[TBL] [Abstract][Full Text] [Related]
6. Significance of MTG8 in leukemogenesis.
Kozu T; Komori A; Sueoka E; Fujiki H; Kaneko Y; Matsui T; Uehara T; Seino Y; Ishii M
Leukemia; 1997 Apr; 11 Suppl 3():297-8. PubMed ID: 9209371
[TBL] [Abstract][Full Text] [Related]
7. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.
Kitabayashi I; Ida K; Morohoshi F; Yokoyama A; Mitsuhashi N; Shimizu K; Nomura N; Hayashi Y; Ohki M
Mol Cell Biol; 1998 Feb; 18(2):846-58. PubMed ID: 9447981
[TBL] [Abstract][Full Text] [Related]
8. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886
[TBL] [Abstract][Full Text] [Related]
9. Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA.
Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
J Cancer Res Clin Oncol; 1996; 122(4):254-6. PubMed ID: 8601580
[TBL] [Abstract][Full Text] [Related]
10. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
[TBL] [Abstract][Full Text] [Related]
11. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
Shimada H; Ichikawa H; Ohki M
Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.
Sakakura C; Yamaguchi-Iwai Y; Satake M; Bae SC; Takahashi A; Ogawa E; Hagiwara A; Takahashi T; Murakami A; Makino K
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11723-7. PubMed ID: 7972130
[TBL] [Abstract][Full Text] [Related]
13. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
14. The AML1/ETO fusion protein activates transcription of BCL-2.
Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
[TBL] [Abstract][Full Text] [Related]
15. Subcellular localization of the oncoprotein MTG8 (CDR/ETO) in neural cells.
Sacchi N; Tamanini F; Willemsen R; Denis-Donini S; Campiglio S; Hoogeveen AT
Oncogene; 1998 May; 16(20):2609-15. PubMed ID: 9632137
[TBL] [Abstract][Full Text] [Related]
16. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
[TBL] [Abstract][Full Text] [Related]
17. Structure and expression pattern of a human MTG8/ETO family gene, MTGR1.
Morohoshi F; Mitani S; Mitsuhashi N; Kitabayashi I; Takahashi E; Suzuki M; Munakata N; Ohki M
Gene; 2000 Jan; 241(2):287-95. PubMed ID: 10675041
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
Kasashima K; Sakota E; Kozu T
Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes.
Szyrach M; Münchberg FE; Riehle H; Nordheim A; Krauter J; Nagel S; Heil G; Heidenreich O
Eur J Biochem; 2001 Jun; 268(12):3550-7. PubMed ID: 11422386
[TBL] [Abstract][Full Text] [Related]
20. Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leukaemia.
Maeda M; Otsuka T; Kimura N; Kozu T; Fukuyama T; Uchida N; Sugio Y; Itoh Y; Iino T; Inaba S; Niho Y
Br J Haematol; 2000 Nov; 111(2):570-9. PubMed ID: 11122105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
